Details

Autor(en) / Beteiligte

• Cavedo, Enrica
• Lista, Simone
• Houot, Marion
• Vergallo, Andrea
• Grothe, Michel J
• Teipel, Stefan
• Zetterberg, Henrik
• Blennow, Kaj
• Habert, Marie-Odile
• Potier, Marie C
• Dubois, Bruno
• Hampel, Harald
• Alzheimer Precision Medicine Initiative

Titel

Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease

Ist Teil von

• Neurology, 2020-01, Vol.94 (1), p.e30

Ort / Verlag

United States

Erscheinungsjahr

2020

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• To investigate whether baseline concentrations of plasma total tau (t-tau) and neurofilament light (NfL) chain proteins are associated with annual percent change (APC) of the basal forebrain cholinergic system (BFCS) in cognitively intact older adults at risk for Alzheimer disease (AD). This was a large-scale study of 276 cognitively intact older adults from the monocentric INSIGHT-preAD (Investigation of Alzheimer's Predictors in Subjective Memory Complainers) cohort. Participants underwent baseline assessment of plasma t-tau and NfL concentrations as well as baseline and 24-month follow-up MRI scans. Linear models with and without influential observations (calculated using the Cook distance) were carried out to investigate the effect of plasma NfL and t-tau concentrations, and their interaction effect with β-amyloid status and genotype, on the APC of the whole BFCS and its anterior (Ch1/2) and posterior (Ch4) subdivisions separately. Higher plasma t-tau concentrations at baseline were associated with higher BFCS rate of atrophy (model without influencers: n = 251, F value = 4.6815; value = 0.031). Subregional analyses showed similar results for both the APC of the Ch1/2 (model without influencers: n = 256, F value = 3.9535, corrected = 0.047) and Ch4 BFCS sectors (model without influencers: n = 253, F value = 4.9090, corrected = 0.047). Baseline NfL, β-amyloid load, and carrier status did not affect APC of the BFCS. Increased concentrations of baseline plasma t-tau may predict in vivo structural BFCS atrophy progression in older adults at risk for AD, independently of β-amyloid status and genotype.